You have searched for "trial"
Showing 1901-1910 of 1928
NEW YORK: For a brief moment earlier this week, it looked like the volatility that’s gripped equity markets virtually all year was ready to recede. Four tumultuous days later, anxiety remains elevated, and traders are betting it’s going to stay that way.
NEW YORK: The S&P 500 and Dow Jones industrial average notched record closing highs on Monday as news of another promising coronavirus vaccine fanned hopes of eradicating COVID-19, while spiking infections and new shutdowns threatened to hobble a recovery from the pandemic recession.
NEW YORK: Asian stocks opened firmer on Tuesday after the S&P 500 and Dow Jones indexes hit record highs on news of another promising coronavirus vaccine, which supported hopes of a quicker economic recovery.
KUALA LUMPUR: Shares in Top Glove Corp Bhd fell 10% on Tuesday after Malaysia tightened movement curbs in an area where the company's dormitories are located to enable targeted coronavirus screenings of workers and residents.
SHANGHAI: China stocks ended lower on Tuesday, weighed by losses in healthcare stocks on concerns over lofty valuations, while more bond defaults hit sentiment.
PARIS: Air cargo operators may struggle to distribute new Covid-19 vaccines effectively unless pandemic travel restrictions are eased, global airlines cautioned.
NEW YORK: U.S. stocks closed steeply lower after a late-session sell-off on Wednesday as investors weighed surging COVID-19 infections and mounting shutdowns against encouraging vaccine developments.
NEW YORK: Oil prices firmed by about 1% on Wednesday on hopes OPEC and its allies will delay a planned increase in oil output and after Pfizer said its COVID-19 vaccine was more effective than previously reported.
LONDON: Trial successes from Pfizer Inc and Moderna Inc have buoyed hopes that a Covid-19 vaccine is coming soon. But much of the world, outside of rich nations like the United States, is counting on another company’s shot to escape the crisis